| Prof. Ram Bilas PachoriIndian Institute of Technology Indore, India Prof. Ram Bilas Pachori's research interests include signal and image processing, biomedical signal processing, non-stationary signal processing, speech signal processing, brain-computer interface, machine learning, and artificial intelligence and the internet of things in healthcare. He was an Associate Editor of IEEE Transactions on Neural Systems and Rehabilitation Engineering (2021-2024). Currently, he is an Associate Editor of Electronics Letters, IEEE Open Journal of Engineering in Medicine and Biology, Computers and Electrical Engineering, and Biomedical Signal Processing and Control. He is also serving as a Handling Editor of Signal Processing and an Editor of IETE Technical Review journal. He is a Fellow of IETE, IEI, and IET. He has authored the textbook titled “Time-Frequency Analysis Techniques and their Applications” (CRC Press, 2023). He has 349 publications, which include journal articles (219), conference papers (91), books (11), and book chapters (28). He has also eight patents, including two granted (Australian patent and Indian patent) and six published (Indian patents). His publications have been cited approximately 17500 times with h-index of 72 according to Google Scholar. |
| Prof. Ming ChenZhejiang University, China Prof. Ming Chen is the director of the Bioinformatics Laboratory at the College of Life Sciences and is the leading figure in the field of bioinformatics at Zhejiang University, China. He obtained his Ph.D. in bioinformatics from Bielefeld University, Germany, in 2004. He was seconded to the Fundamental Research Department of the Ministry of Science and Technology, served as president assistant, and was specially appointed dean at Inner Mongolia Minzu University. Prof. Chen's research work covers bioinformatics, systems biology, non-coding RNA transcriptomics, and precision medicine. He has published over 200 academic papers in peer-viewed journals such as Cell, Nature, Nucleic Acids Research, Bioinformatics, etc., with a Google Scholar H-index of over 50. He has been included in the list of the top 2% of scientists in the world. |
| Zhengju ChenBeijing Baiti Biotechnology Co., Ltd., China The CEO of Beijing Baitai Bio, a researcher in nucleic acid drug development based on nanocarriers at Pulue Medical Translational Research Institute, holds a Ph.D. from Peking University Health Science Center and completed postdoctoral research at Peking University. He is a specially appointed expert of Zhongbolian. With many years of dedicated experience in the field of nanocarriers and nucleic acid drugs, he has worked at key laboratories under the Ministry of Education and national key laboratories. Leveraging a solid academic foundation, he has published over ten academic papers in high-impact journals. He leads a team conducting extensive research and translational work on nucleic acid drugs, spearheading the development of more than ten related technological invention patents. He also possesses rich experience in initiating and completing major national projects and grants from the National Natural Science Foundation, and leads multiple national-level nucleic acid drug development projects within the company. In addition, he serves as a long-term consultant for several medical expert teams. By combining expertise in academia, industry, and resources, he continuously drives innovation and clinical translation of nucleic acid drug development in the company. |
